Efficacy and safety of a single 2-g oral dose of extended-release azithromycin for treatment of gonococcal urethritis.

Efficacy and safety of a single 2-g oral dose of extended-release azithromycin for treatment of gonococcal urethritis. - A single 2-g oral dose of extended-release azithromycin for treatment of gonococcal urethritis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013774

Enrollment

100

Registered

2014-04-21

Start date

2009-04-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

male gonococcal urethritis

Interventions

A single 2-g oral dose of extended-release azithromycin

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: male gonococcal urethritis

Exclusion criteria

Exclusion criteria: Allergy for macrolides, severe renal dysfunction, severe cardiac disease, severe hepatic dysfunction

Design outcomes

Primary

Measure	Time frame
bacteriological efficacy	—

Countries

Japan

Contacts

Public ContactMitsuru Yasuda

Gifu University Hospital Department of Urology

super7@gifu-u.ac.jp058-230-6338

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026